GELION PLC

Registration Form • Nov 25, 2021

National Storage Mechanism | Additional information

RNS Number : 5268T

Gelion PLC

25 November 2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND DEPENDENCIES, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) (COLLECTIVELY, THE "UNITED STATES"), CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW

25 November 2021 

Gelion PLC

("Gelion" or "the Company")

Publication of Admission Document and Investor Presentation

Gelion PLC, a UK-Australian energy storage innovator, is pleased to announce that the Company's Admission Document in relation to the admission of its ordinary shares to trading on AIM ("Admission") is available on the Company's website at https://www.gelion.com/.

Admission and the commencement of trading in the Company's ordinary shares is expected to take place at 8.00am GMT on 30 November 2021.

Investor Presentation

Gelion will also give a live presentation via the Investor Meet Company platform on the Company's Admission to trading on AIM on 30 November 2021 at 11:00am GMT. Investors can sign up to Investor Meet Company for free and register for the event at: https://www.investormeetcompany.com/gelion-plc/register-investor.

Andrew Grimes, CEO, Stuart Rayner, Commercial Director, and Professor Thomas Maschmeyer, Founder and Principal Technology Advisor, will present an overview of Gelion, its revolutionary battery technology for the stationary storage of renewable energy and provide detail on the Company's future plans.

The presentation is open to all existing shareholders, potential investors and other interested parties. Questions can be submitted pre-event via the Investor Meet Company dashboard or gelion@tavistock.co.uk up until 9:00am GMT the day before the meeting or at any time during the live presentation.

While the Company will not be in a position to answer every question, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform. 

A copy of the presentation will be available on the Company's website https://www.gelion.com/.

For further information, please visit www.gelion.com or contact:

Gelion PLC Andrew Grimes, Chief Executive Officer Thomas Maschmeyer, Founder and Principal Technology Advisor Marcus Strom, Corporate Communications	via Tavistock
finnCap Capital Markets (Nominated Adviser and Sole Broker)	Tel: +44 020 7220 0500
Corporate Finance Christopher Raggett Seamus Fricker Fergus Sullivan ECM Barney Hayward
Tavistock (Financial PR Adviser)	Tel: +44 207 920 3150
Simon Hudson Nick Elwes Rebecca Hislaire Matthew Taylor	gelion@tavistock.co.uk

About Gelion PLC

Gelion was founded as a spin-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, one of the world's leading chemists who was awarded the Australian Prime Minister's Prize for Innovation 2020.

Gelion is a global renewable-energy storage innovator. By designing leading-edge battery technology for stationary and mobile energy, the Company supports the transition to a sustainable economy while delivering value for customers and investors.

·    The Gelion Endure battery uses low-cost, abundant raw materials and is based on a chemistry that is highly resistant to fire and can operate off-grid at high ambient temperatures.

·    With applications in agriculture, mining, water management and irrigation the battery is highly adaptable for off-grid use.

The batteries are also scalable, using lead-acid battery manufacturing technology, and the Company expects to develop megawatt-hour capacity for large-scale infrastructure, including for solar and wind farms.

In addition to investing in the growth of its zinc-bromide technology, the Company will use funding to develop its mobile energy division to enhance existing lithium-ion and lithium-sulfur battery technologies used in electric vehicles and the emerging market in electric aviation.

For the mobile market, Gelion's technology pipeline includes:

·    Highly tuneable, low-cost silicon nanoparticle additives for next-generation advanced lithium-ion batteries, which are safer and have higher energy density. 

·    A low-cost additive, which increases the lifetime of lithium-sulfur batteries by more than four times, delivering up to three times higher energy by weight than conventional lithium-ion batteries.

Using additive technology developed by its R&D team, which cooperates closely with scientists at the School of Chemistry and the University of Sydney Nano Institute, Gelion will develop and license additives for advanced lithium-silicon and lithium-sulfur technologies for ultra-high-density batteries to extend the cycle-life and safety of mobile energy storage.

Gelion also recently announced a partnership with Battery Energy Power Solutions in Sydney to manufacture and distribute its zinc-bromide batteries for the Australian market.

Important Notices

This announcement does not constitute or form part of any offer or invitation to sell or issue or any solicitation of any offer to purchase or subscribe for any securities in any jurisdiction, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment whatsoever relating to any securities.

Recipients of this announcement who intend to purchase or subscribe for shares in the Company are reminded that any such purchase or subscription must only be made solely on the basis of the information contained in the final admission document relating to the Company.

This document does not constitute an offer of securities in the United States or to US Persons. Shares of the Company may not be offered or sold in the United States or to US Persons without being registered under the United States Securities Act of 1933, as amended ("U.S. Securities Act") or an available exemption from such registration. The Company does not presently intend to register any securities under the U. S. Securities Act and no public offering of shares is being or will be made in the United States or to US Persons.

The information contained in this announcement is not for publication or distribution in, into or from the United States, Canada, Australia or Japan. Any failure to comply with these restrictions may constitute a violation of United States, Canadian, Australian or Japanese securities laws. This document (and the information contained herein) does not contain or constitute an offer of securities for sale, or solicitation of an offer to purchase securities, in the United States, Australia, New Zealand, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an offer or solicitation would be unlawful.  No money, securities or other consideration is being solicited and, if sent in response to the information contained herein, will not be accepted.

finnCap Ltd ("finnCap") which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with Admission. finnCap will not regard any other person as its client in relation to Admission and will not be responsible to anyone other than the Company for providing the regulatory protections afforded to its clients, nor for providing advice in relation to the contents of this announcement or any transaction, arrangement or other matter referred to herein.

For the avoidance of doubt, the contents of the Group's websites are not incorporated by reference into, and do not form part of, this announcement.

--ENDS--

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFFFEVLTLSFIL